ProVise Management Group’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,980	Closed	-$1.04M	–	347
2023 Q1	$1.04M	Buy	+47,980	New	+$1.04M	0.1%	164